This study is being done to examine the effects of a medication called mifepristone in children with Cushing's disease. This medication has been approved by the Food and Drug Administration (FDA) for use in adult patients with Cushing's syndrome. It is not FDA approved for use in children. The study will investigate how children's bodies absorb and process mifepristone, how it works in children and what effect it has on the use of sugar in the body, on the child's weight and on growth hormone. An important part of the study is to determine the proper dosing and to evaluate the side effects of mifepristone in children.
Children 6 to 17 years old will be enrolled in the study if they have had surgery for Cushing's disease and currently have elevated cortisol levels.
To get started, please click here.